December 28, 2016
Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director of Project Management. This newly created key leadership position will elevate internal collaboration for the organization as it develops and commercializes first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Seasoned executives with CVOT project management leadership are encouraged to contact Bonnie Stofer for confidential consideration at bonnie@chasegroup.com.
